Mayne Pharma Group Limited

Symbol: MYX.AX

ASX

6.8

AUD

Market price today

  • -2.3865

    P/E Ratio

  • -0.0091

    PEG Ratio

  • 578.51M

    MRK Cap

  • 0.00%

    DIV Yield

Mayne Pharma Group Limited (MYX-AX) Financial Statements

On the chart you can see the default numbers in dynamics for Mayne Pharma Group Limited (MYX.AX). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Mayne Pharma Group Limited, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

balance-sheet.row.cash-and-short-term-investments

0229.297.198.4
138.2
89.6
102.4
70.7
50.4
60.5
15.2
20.8
11.6
5.8
19.7
7.9
11.5
15.3

balance-sheet.row.short-term-investments

0127.51.30
0
0.6
8.3
6.2
2.9
1.3
0.4
1.8
0
0
0
0
0
0

balance-sheet.row.net-receivables

0209.5283193.3
233.3
251
251.7
223.6
91.7
63.1
29.2
24.6
3.8
5.7
6
0
0
0.1

balance-sheet.row.inventory

082.7108.9102.5
94
100.3
82.2
106.4
38.9
22.4
17.2
13.6
7.2
6.4
6.5
0
0
0

balance-sheet.row.other-current-assets

032.222.622.3
25.5
31
51.3
22.9
896
10.8
4.2
1.3
0.6
0.3
0.3
0
0.1
0.1

balance-sheet.row.total-current-assets

0553.6511.6416.5
490.9
471.9
480.8
422.1
1077.1
156.8
65.9
61.9
23.3
18.8
32.5
8
11.6
15.5

balance-sheet.row.property-plant-equipment-net

051.5225.9221.6
238.2
236
230.1
189.3
84.4
59.6
53.4
55
22.2
21.5
21
0
0
0.1

balance-sheet.row.goodwill

0022.120.3
22.2
21.7
20.6
58.2
60.1
58.4
47.5
47.2
0.4
0.4
0.4
0
0
0

balance-sheet.row.intangible-assets

0617.3427.5636.2
962.3
722.5
931.7
1085.6
200.3
193
60.2
68.3
4.2
8.2
14.2
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0617.3449.6656.5
984.5
744.3
952.3
1143.8
260.4
251.4
107.7
115.5
4.2
8.2
14.2
0
0
0

balance-sheet.row.long-term-investments

00-22.1-20.3
1137.7
830.4
1102
1252.4
295.2
301.4
4.1
152.5
0
0
0
0
0
0

balance-sheet.row.tax-assets

023.4133.7187.2
150.7
149.9
80.4
80.7
49.6
9.6
1.3
1
4.3
5.2
3.3
0
0
0

balance-sheet.row.other-non-current-assets

02.34.516.7
-1159.8
-980.3
-1182.4
-80.7
-49.6
-9.6
-1.3
0
0
0
0
0
0
0

balance-sheet.row.total-non-current-assets

0694.5791.51061.6
1351.3
980.3
1182.4
1333.1
344.9
311
165.2
171.5
30.7
34.8
38.6
0
0
0.1

balance-sheet.row.other-assets

0000
0
183.5
167.4
152.8
103.8
61.1
34.8
0
0
0
0
0
0
0

balance-sheet.row.total-assets

01248.11303.11478.1
1842.2
1635.7
1830.5
1908
1525.8
528.9
265.8
233.4
53.9
53.7
71.1
8
11.7
15.5

balance-sheet.row.account-payables

03263.642.4
29.8
50.4
63.9
66.6
64.1
51.6
7.1
10.5
4.2
3.8
3.9
0.2
0.2
1

balance-sheet.row.short-term-debt

014.440854
44.8
50.9
0.1
13.1
0.5
0
2.4
7.5
0
2.3
7.6
0
0
0

balance-sheet.row.tax-payables

001.20
0
0
0
0
12.3
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

028.55.7285.8
344.4
318.5
374.1
327
76.2
60.8
45.7
39.2
0
0
1
0
0
0

Deferred Revenue Non Current

04.607
8.8
267.4
324.8
250.7
16.7
19.4
23.9
0.8
0
0
1.5
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0256.9156.9125.9
143.6
108.1
116.8
113.3
959.8
43.5
20.9
18.1
8.1
5.8
6.5
0
0
0

balance-sheet.row.total-non-current-liabilities

0302.8135.6484
580.7
318.5
374.1
327
76.2
60.8
45.7
70.4
11
14.6
22.4
0
0
0

balance-sheet.row.other-liabilities

0000
0
92.4
40.5
75.6
49.1
50.9
30.5
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

04.65.77
8.8
0
0
0.1
0.2
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0613.8764.9706.6
799.9
622.3
595.4
595.6
1149.6
206.7
106.5
112.5
23.3
29.5
45.6
0.3
0.3
1

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

01233.71238.51238.5
1238.6
1140
1131.8
1130.4
263.2
255.8
137.5
118.3
32
31.9
29.6
15.9
15.9
15.9

balance-sheet.row.retained-earnings

0-769.8-840.3-559.1
-350.6
-257.9
23.5
150.1
61.5
24.2
16.4
-4.9
-2.5
-8.7
-5.8
-9.1
-5.3
-1.8

balance-sheet.row.accumulated-other-comprehensive-income-loss

0170.4147.788.9
149.6
125
71.2
23.3
39.1
30.9
5.4
7.5
1.1
1
1.7
0.9
0.9
0.4

balance-sheet.row.other-total-stockholders-equity

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-stockholders-equity

0634.4545.9768.4
1037.5
1007.2
1226.5
1303.8
363.7
310.9
159.3
120.9
30.6
24.2
25.5
7.7
11.4
14.5

balance-sheet.row.total-liabilities-and-stockholders-equity

01248.11303.11478.1
1842.2
1655.5
1845.7
1927.5
1543.6
528.9
265.8
233.4
53.9
53.7
71.1
8
11.7
15.5

balance-sheet.row.minority-interest

00-7.73.2
4.8
6.3
8.7
8.6
12.5
11.3
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

0634.4538.2771.6
1042.3
1013.5
1235.2
1312.4
376.2
322.2
159.3
120.9
30.6
24.2
25.5
7.7
11.4
14.5

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0127.51.3-20.3
1137.7
0.6
8.3
6.2
2.9
1.3
4.5
1.8
0
0
0
0
0
0

balance-sheet.row.total-debt

047.5413.7346.8
398
369.4
374.2
340.2
76.8
61.8
48
46.7
0
2.3
8.6
0
0
0

balance-sheet.row.net-debt

0-54.2316.6248.5
259.9
280.4
286.9
277.2
29.4
2.6
33.2
27.8
-11.6
-3.5
-11.1
-7.9
-11.5
-15.3

Cash Flow Statement

The financial landscape of Mayne Pharma Group Limited has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

cash-flows.row.net-income

0-317.4-209.5-208.4
-92.8
-279.2
-134
88.6
37.4
7.8
21.3
-2.8
6.2
1.7
3.3
-3.8
-3.5
-1.8

cash-flows.row.depreciation-and-amortization

065.455.268.2
84.6
89.4
76.4
70.4
20.2
13.1
9.7
3.7
3.8
6.1
6.6
0
0
0

cash-flows.row.deferred-income-tax

05063.4-43.9
-42.6
-50.6
-0.2
-32.6
-25.7
30.9
6
6.1
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

06.84.67.7
7
9
14.5
11.2
5.1
1.8
1.4
0.7
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0145.4-8.9-13.6
50.2
3
-0.7
-225.8
-42.9
-32.7
-7.4
-6.8
0
0
0
0
0
0

cash-flows.row.account-receivables

0118.7-66.1-3.2
67.5
9.4
-17.8
-146.1
-26.3
-30.3
-4
-5.5
0
0
0
0
0
0

cash-flows.row.inventory

0-12.1-2.4-25.9
13.1
-6.4
17.1
-79.7
-16.7
-2.5
-3.4
-1.3
0
0
0
0
0
0

cash-flows.row.account-payables

045.360.716.4
-26.3
-30
10.1
35.9
51.4
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-6.5-1.1-0.9
-4.1
30
-10.1
-35.9
-51.4
0
0
0
0
0
0
0
0
0

cash-flows.row.other-non-cash-items

06.678.6237.3
93.5
335
165.4
73
59.5
32.5
1.2
12.1
3.4
-3.7
0.4
0.1
0.4
0.6

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-219.6-11.9-25.1
-47.1
-11.9
-54.2
-104.4
-29.6
-4.2
-4.2
-21.1
-2.5
-2.1
-0.4
0
0
-0.1

cash-flows.row.acquisitions-net

0842.25.20
0
0
-0.2
0.8
0
1
-0.8
-103.1
0
0
-18.4
0
0
0

cash-flows.row.purchases-of-investments

0-127.500
0
-0.5
-0.5
0
0
-1
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
0
0.7
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

0-21.6-21.8-24.1
-8.8
-79.3
-64.2
-994.2
-54.2
-91.4
-45.8
-1.3
0
0
0
0
0
0

cash-flows.row.net-cash-used-for-investing-activites

0473.5-28.5-49.2
-55.9
-91.7
-118.3
-1097.8
-83.8
-95.5
-50.8
-125.5
-2.5
-2.1
-18.8
0
0
-0.1

cash-flows.row.debt-repayment

0-376-39.8-25.8
-8.3
-62.5
-0.1
-0.5
-0.3
-59.7
-6.4
-1.1
-2.3
-5.1
-2.7
0
0
0

cash-flows.row.common-stock-issued

02.300
0.1
7.1
1.5
863.8
4.7
118.6
18.1
89.6
0
1.5
14.2
0
0
16.9

cash-flows.row.common-stock-repurchased

0-6.200
0
0
0
-4.8
0
-4.6
-0.7
-4
0
0
-0.8
0
-0.7
-0.3

cash-flows.row.dividends-paid

0-45.300
0
0
0
-858.5
0
-54.3
-11.1
-45.7
0
-4.5
-10.7
0
0
0

cash-flows.row.other-financing-activites

0-6.276.8-3
12.8
39.9
18.8
271.2
13.7
60.8
8.8
87.4
-2.9
-6.6
20.4
0
0
0

cash-flows.row.net-cash-used-provided-by-financing-activities

0-431.537-28.8
4.5
-15.6
20.2
1129.7
18
115.1
19.9
126.2
-5.2
-14.7
20.3
0
-0.7
16.6

cash-flows.row.effect-of-forex-changes-on-cash

0-2.96.8-9
0.4
2.3
1
-1.1
0.6
2.4
-0.2
1
0.1
-1.2
0
0
0
0

cash-flows.row.net-change-in-cash

04.6-1.3-39.8
48.8
1.7
24.3
15.2
-11.7
44.5
-5
7.3
5.8
-13.9
11.8
-3.6
-3.8
15.3

cash-flows.row.cash-at-end-of-period

0101.797.198.4
138.2
89
87.3
63
47.9
59.6
15.1
18.9
11.6
5.8
19.7
7.9
11.5
15.3

cash-flows.row.cash-at-beginning-of-period

097.198.4138.2
89.4
87.3
63
47.9
59.6
15.1
20.1
11.6
5.8
19.7
7.9
11.5
15.3
0

cash-flows.row.operating-cash-flow

0-43.1-16.647.3
99.8
106.6
121.5
-15.2
53.5
22.4
26.1
6.8
13.4
4.1
10.3
-3.6
-3
-1.2

cash-flows.row.capital-expenditure

0-219.6-11.9-25.1
-47.1
-11.9
-54.2
-104.4
-29.6
-4.2
-4.2
-21.1
-2.5
-2.1
-0.4
0
0
-0.1

cash-flows.row.free-cash-flow

0-262.7-28.522.2
52.7
94.7
67.3
-119.7
23.9
18.2
21.9
-14.2
10.8
2
9.9
-3.6
-3
-1.3

Income Statement Row

Mayne Pharma Group Limited's revenue saw a change of NaN% compared with the previous period. The gross profit of MYX.AX is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

income-statement-row.row.total-revenue

0183.6157.1400.8
457
525.2
530.3
572.6
267.3
140.3
142.2
82.3
51.1
48.8
37
1
0.8
0.1

income-statement-row.row.cost-of-revenue

0156.7133.4273.8
316
316.2
346.1
324
115.2
61.4
68.2
44.4
29.3
26.9
19.1
0
0
0

income-statement-row.row.gross-profit

026.823.7127
140.9
209
184.2
248.6
152
78.9
74
37.8
21.7
21.9
17.9
1
0.8
0.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

012.674.46.4
15.4
-7.9
4.7
27.5
-1.3
4
3.6
-8.4
4.3
2.1
-0.3
0.6
-0.1
0

income-statement-row.row.operating-expenses

0213.3145.6125.7
153.1
179.9
147.1
126.3
96.5
70
50.3
31.9
17.3
21.6
15.5
5.2
4.3
2

income-statement-row.row.cost-and-expenses

0370279399.4
469.1
496
493.2
450.3
211.8
131.5
118.5
76.3
48.4
49.3
34.6
5.2
4.3
2

income-statement-row.row.interest-income

06.70.50.7
0.8
1
0.1
0.3
0.5
0.4
0.3
0.4
0.2
0.3
0.2
0.4
0.8
0.1

income-statement-row.row.interest-expense

010.511.513.3
16.8
18.1
15.8
11.5
2.5
5.9
4.3
2.3
0
1.8
1.5
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-83.3-23.7-265.3
-123.2
-382.9
-203.9
-6.3
-5.7
3
3.6
-8.4
3.3
0
-0.3
0.6
-0.1
0.1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

012.674.46.4
15.4
-7.9
4.7
27.5
-1.3
4
3.6
-8.4
4.3
2.1
-0.3
0.6
-0.1
0

income-statement-row.row.total-operating-expenses

0-83.3-23.7-265.3
-123.2
-382.9
-203.9
-6.3
-5.7
3
3.6
-8.4
3.3
0
-0.3
0.6
-0.1
0.1

income-statement-row.row.interest-expense

010.511.513.3
16.8
18.1
15.8
11.5
2.5
5.9
4.3
2.3
0
1.8
1.5
0
0
0

income-statement-row.row.depreciation-and-amortization

065.455.268.2
84.6
94.5
79.9
73.7
21.4
13.5
9.9
7.4
3.8
6.1
5.3
0
0
0

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-186.4-121.91.4
-12.1
29.2
37.1
122.3
55.5
17.2
32.4
6
2.5
-0.8
0.8
-5.2
-4.2
-2

income-statement-row.row.income-before-tax

0-269.7-145.6-263.9
-135.4
-353.7
-166.8
115.9
49.8
11.2
28
-0.7
7.8
-1.5
0.6
-4.1
-3.5
-1.8

income-statement-row.row.income-tax-expense

047.774.5-54.8
-40.8
-71.6
-32.5
29.9
15.3
3.7
6.7
2.1
1.6
-3.2
-2.6
-0.4
-0.1
0.1

income-statement-row.row.net-income

0-316.4-281.3-208.4
-92.8
-279.2
-134
88.6
37.4
7.8
21.3
-2.8
6.2
1.7
3.3
-3.8
-3.5
-1.8

Frequently Asked Question

What is Mayne Pharma Group Limited (MYX.AX) total assets?

Mayne Pharma Group Limited (MYX.AX) total assets is 1248134000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.437.

What is company free cash flow?

The free cash flow is -0.359.

What is enterprise net profit margin?

The net profit margin is -0.897.

What is firm total revenue?

The total revenue is -0.381.

What is Mayne Pharma Group Limited (MYX.AX) net profit (net income)?

The net profit (net income) is -316419000.000.

What is firm total debt?

The total debt is 47505000.000.

What is operating expences number?

The operating expences are 213282000.000.

What is company cash figure?

Enretprise cash is 0.000.